The following is a summary of “Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis,” ...
Dr. Lucas Brown, DAOM, LAc, spoke with Studio 512 about how his clinic, Rosedale Acupuncture & Wellness, can help with ...
Based on work Dr. Petrylak presented at ASCO 2024 looking at dose adjustment and efficacy of enfortumab vedotin, most ...
A 72-year-old Surprise man named Gregory Province nearly lost his foot to peripheral arterial disease. His Banner Health ...
The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.
An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...
For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).
GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback